PL1928872T3 - Nowe sulfonylopirole jako inhibitory HDAC - Google Patents
Nowe sulfonylopirole jako inhibitory HDACInfo
- Publication number
- PL1928872T3 PL1928872T3 PL06793379T PL06793379T PL1928872T3 PL 1928872 T3 PL1928872 T3 PL 1928872T3 PL 06793379 T PL06793379 T PL 06793379T PL 06793379 T PL06793379 T PL 06793379T PL 1928872 T3 PL1928872 T3 PL 1928872T3
- Authority
- PL
- Poland
- Prior art keywords
- hdac
- inhibitors
- sulphonylpyrroles
- novel
- novel sulphonylpyrroles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05108728 | 2005-09-21 | ||
| PCT/EP2006/066197 WO2007039404A1 (en) | 2005-09-21 | 2006-09-08 | Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
| EP06793379A EP1928872B1 (en) | 2005-09-21 | 2006-09-08 | Novel sulphonylpyrroles as inhibitors of hdac |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1928872T3 true PL1928872T3 (pl) | 2012-08-31 |
Family
ID=37035343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06793379T PL1928872T3 (pl) | 2005-09-21 | 2006-09-08 | Nowe sulfonylopirole jako inhibitory HDAC |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8232297B2 (pl) |
| EP (1) | EP1928872B1 (pl) |
| JP (1) | JP5305910B2 (pl) |
| KR (1) | KR101256846B1 (pl) |
| CN (1) | CN101268070B (pl) |
| AR (1) | AR057824A1 (pl) |
| AT (1) | ATE549333T1 (pl) |
| AU (1) | AU2006298882B2 (pl) |
| BR (1) | BRPI0617167B8 (pl) |
| CA (1) | CA2622673C (pl) |
| CY (1) | CY1112780T1 (pl) |
| DK (1) | DK1928872T3 (pl) |
| EA (1) | EA016345B1 (pl) |
| ES (1) | ES2381962T3 (pl) |
| HR (1) | HRP20120399T1 (pl) |
| IL (1) | IL189782A (pl) |
| NO (1) | NO341744B1 (pl) |
| NZ (1) | NZ566074A (pl) |
| PL (1) | PL1928872T3 (pl) |
| PT (1) | PT1928872E (pl) |
| RS (1) | RS52383B (pl) |
| SI (1) | SI1928872T1 (pl) |
| TW (1) | TWI406846B (pl) |
| WO (1) | WO2007039404A1 (pl) |
| ZA (1) | ZA200801394B (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| EP2298311B1 (en) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| EP1636585B2 (en) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| US7842820B2 (en) | 2004-03-11 | 2010-11-30 | 4Sc Ag | Sulfonylpyrroles |
| DE602006007558D1 (de) | 2005-03-15 | 2009-08-13 | 4Sc Ag | N-sulfonylpyrrole und ihre verwendung als histondeacetylaseinhibitoren |
| KR101256846B1 (ko) | 2005-09-21 | 2013-04-24 | 4에스체 악티엔게젤샤프트 | Ｈｄａｃ의 억제제로서의 신규한 설포닐피롤 |
| EA018698B1 (ru) * | 2005-09-21 | 2013-10-30 | 4Сц Аг | Сульфонилпирролгидрохлориды как ингибиторы гистондезацетилазы |
| EP2100882A1 (en) * | 2008-03-12 | 2009-09-16 | 4Sc Ag | (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts |
| EP2100878A1 (en) * | 2008-03-12 | 2009-09-16 | 4Sc Ag | Novel method for the production of sulphonylpyrroles as HDAC inhibitors |
| AU2009289649B2 (en) | 2008-09-03 | 2016-05-05 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| WO2012118782A1 (en) | 2011-02-28 | 2012-09-07 | Repligen Corporation | Histone deacetylase inhibitors |
| DK2760471T3 (en) * | 2011-09-30 | 2017-05-08 | Dana Farber Cancer Inst Inc | THERAPEUTIC PEPTIDES |
| WO2013101600A1 (en) * | 2011-12-29 | 2013-07-04 | Pharmacyclics, Inc. | Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8 |
| CA2861010A1 (en) | 2012-01-13 | 2013-07-18 | Xiao Xu | Heterocyclic compounds and uses as anticancer agents |
| US9034885B2 (en) | 2012-01-13 | 2015-05-19 | Acea Biosciences Inc. | EGFR modulators and uses thereof |
| US9464089B2 (en) | 2012-01-13 | 2016-10-11 | Acea Biosciences Inc. | Heterocyclic compounds and uses thereof |
| HRP20170311T1 (hr) * | 2012-08-06 | 2017-04-21 | Acea Biosciences Inc. | Novi spojevi pirolopirimidina kao inhibitori protein kinaza |
| RU2665554C2 (ru) | 2013-03-15 | 2018-08-31 | Байомарин Фармасьютикал Инк. | Ингибиторы hdac |
| BR112016000195A8 (pt) | 2013-07-11 | 2019-12-31 | Acea Biosciences Inc | compostos heterocíclicos, composição farmacêutica, combinação, seu uso, e método para inibir uma atividade da tirosina quinase btk ou jak, egfr, alk, pdgfr, blk, bmx/etk, flt3(d835y), itk, tec, txk, e suas respectivas vias |
| EP3359159B1 (en) | 2015-10-09 | 2023-06-07 | ACEA Therapeutics, Inc. | Pharmaceutical compositions of a pyrrolopyrimidine kinase inhibitor, and methods of making same |
| CN105622680B (zh) * | 2015-12-22 | 2018-01-19 | 杭州卢普生物科技有限公司 | 一种舒尼替尼衍生物及其制备方法和应用 |
| WO2017178577A1 (en) | 2016-04-14 | 2017-10-19 | 4Sc Ag | Medical application of resminostat in asian patients |
| AU2017408099A1 (en) | 2017-04-07 | 2019-11-07 | ACEA Therapeutics, Inc. | Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same |
| TW201912183A (zh) | 2017-08-31 | 2019-04-01 | 德商４Ｓｃ製藥公司 | Hdac抑制劑與抗代謝藥劑組合用於癌症治療 |
| CN110496136A (zh) * | 2018-05-17 | 2019-11-26 | 王孝恩 | 锂制剂在制备治疗或预防癌症药物中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960787A (en) | 1989-02-06 | 1990-10-02 | Ciba-Geigy Corporation | Certain pyrrolyl-substituted hydroxamic acid derivatives |
| DE69221290T2 (de) * | 1991-12-10 | 1998-01-15 | Shionogi & Co | Auf aromatischen sulfonamiden basierende hydroxamsäurederivate |
| CA2223154A1 (en) * | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| EP1259506A1 (en) | 1999-11-23 | 2002-11-27 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| KR20100035666A (ko) | 1999-11-23 | 2010-04-05 | 메틸진 인크. | 히스톤 디아세틸라제의 억제제 |
| US6521618B2 (en) * | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| MXPA04001253A (es) | 2001-08-09 | 2004-06-03 | Ono Pharmaceutical Co | Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo. |
| US7868204B2 (en) * | 2001-09-14 | 2011-01-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
| CA2465978C (en) | 2001-09-14 | 2015-04-07 | Soon Hyung Woo | Inhibitors of histone deacetylase |
| JP2006512306A (ja) | 2002-08-29 | 2006-04-13 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途 |
| GB0226855D0 (en) | 2002-11-18 | 2002-12-24 | Queen Mary & Westfield College | Histone deacetylase inhibitors |
| WO2005020921A2 (en) | 2003-08-29 | 2005-03-10 | Exelixis, Inc. | C-kit modulators and methods of use |
| US20080242681A1 (en) | 2004-01-22 | 2008-10-02 | Altana Pharma Ag | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors |
| US20050197336A1 (en) | 2004-03-08 | 2005-09-08 | Miikana Therapeutics Corporation | Inhibitors of histone deacetylase |
| US7842820B2 (en) * | 2004-03-11 | 2010-11-30 | 4Sc Ag | Sulfonylpyrroles |
| US7345043B2 (en) * | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| US7432808B2 (en) | 2004-12-15 | 2008-10-07 | Intel Corporation | Wireless module enabled component carrier for parts inventory and tracking |
| DE602006007558D1 (de) * | 2005-03-15 | 2009-08-13 | 4Sc Ag | N-sulfonylpyrrole und ihre verwendung als histondeacetylaseinhibitoren |
| WO2006105979A1 (en) | 2005-04-07 | 2006-10-12 | Nycomed Gmbh | Sulfonylpyrroles as histone deacetylase inhibitors |
| EA018698B1 (ru) * | 2005-09-21 | 2013-10-30 | 4Сц Аг | Сульфонилпирролгидрохлориды как ингибиторы гистондезацетилазы |
| KR101256846B1 (ko) | 2005-09-21 | 2013-04-24 | 4에스체 악티엔게젤샤프트 | Ｈｄａｃ의 억제제로서의 신규한 설포닐피롤 |
-
2006
- 2006-09-08 KR KR1020087008938A patent/KR101256846B1/ko active Active
- 2006-09-08 CN CN2006800347491A patent/CN101268070B/zh active Active
- 2006-09-08 RS RS20120248A patent/RS52383B/sr unknown
- 2006-09-08 PT PT06793379T patent/PT1928872E/pt unknown
- 2006-09-08 DK DK06793379.6T patent/DK1928872T3/da active
- 2006-09-08 EA EA200800700A patent/EA016345B1/ru not_active IP Right Cessation
- 2006-09-08 WO PCT/EP2006/066197 patent/WO2007039404A1/en not_active Ceased
- 2006-09-08 AT AT06793379T patent/ATE549333T1/de active
- 2006-09-08 SI SI200631335T patent/SI1928872T1/sl unknown
- 2006-09-08 PL PL06793379T patent/PL1928872T3/pl unknown
- 2006-09-08 NZ NZ566074A patent/NZ566074A/en not_active IP Right Cessation
- 2006-09-08 ES ES06793379T patent/ES2381962T3/es active Active
- 2006-09-08 US US11/992,015 patent/US8232297B2/en active Active
- 2006-09-08 JP JP2008530492A patent/JP5305910B2/ja active Active
- 2006-09-08 AU AU2006298882A patent/AU2006298882B2/en not_active Ceased
- 2006-09-08 HR HRP20120399TT patent/HRP20120399T1/hr unknown
- 2006-09-08 BR BRPI0617167A patent/BRPI0617167B8/pt not_active IP Right Cessation
- 2006-09-08 CA CA2622673A patent/CA2622673C/en active Active
- 2006-09-08 EP EP06793379A patent/EP1928872B1/en active Active
- 2006-09-21 AR ARP060104135A patent/AR057824A1/es active IP Right Grant
- 2006-09-21 TW TW095135005A patent/TWI406846B/zh not_active IP Right Cessation
-
2008
- 2008-02-11 ZA ZA2008/01394A patent/ZA200801394B/en unknown
- 2008-02-26 IL IL189782A patent/IL189782A/en active IP Right Grant
- 2008-04-14 NO NO20081797A patent/NO341744B1/no unknown
-
2012
- 2012-05-21 CY CY20121100465T patent/CY1112780T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200801394B (en) | Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles | |
| ZA200706345B (en) | Amino-pyridines as inhibitors of ß-secretase | |
| ZA200802585B (en) | Pyridopyrimidinone inhibitors of Pl3Kα | |
| IL190292A0 (en) | PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka | |
| IL197752A0 (en) | Hdac inhibitors | |
| ZA200707650B (en) | Azolylacylguanidines as ß-secretase inhibitors | |
| EP1844003A4 (en) | NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR | |
| PL1725528T3 (pl) | Sulfonylopirole jako inhibitory HDAC | |
| PL2335782T3 (pl) | Zastosowanie kompozycji zawierającej HFCO-1233zd | |
| ZA200805152B (en) | Inhibitors of IAP | |
| EP2200439A4 (en) | HDAC INHIBITORS | |
| EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
| ZA200708932B (en) | Manufacture of ferroalloys | |
| ZA200805000B (en) | Compositions of lipoxygenase inhibitors | |
| ZA200807862B (en) | Azolopyrimidines as inhibitors of cannabinoid 1 activity | |
| IL185757A0 (en) | Methods of decreasing calcifcation | |
| SI1912640T1 (sl) | Uporaba inhibitorja hdac panobinostata za zdravljenje mieloma | |
| DK2392335T3 (en) | Use of 24-norUDCA | |
| GB0624187D0 (en) | HDAC inhibitors | |
| ZA200705383B (en) | Benzoyl-tetrahydropyridine as GlyT-1 inhibitors | |
| GB0512459D0 (en) | Removal of nitrogen compounds | |
| GB0506443D0 (en) | Novel inhibitors | |
| HK1109775A (en) | Amino-pyridines as inhibitors of beta-secretase | |
| PT1899354E (pt) | Síntese de desoxibiotinil-hexametilenodiaminadota | |
| AU2005906584A0 (en) | Use of Inhibitors of Prolyl-4-Hydroxylases |